Chemed Corp: Form 10-Q for the period ended Jun 30, 2017
Filed with the SEC on Jul 31, 2017 and accepted by EDGAR at Jul 31, 2017, 14:57 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2017-04-01 to 2017-06-30 | $415.1m | us-gaap:SalesRevenueNet |
| Revenue | 6 months2017-01-01 to 2017-06-30 | $820.9m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2017-04-01 to 2017-06-30 | $285.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2017-01-01 to 2017-06-30 | $571.0m | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2017-04-01 to 2017-06-30 | $68.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2017-01-01 to 2017-06-30 | $138.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-04-01 to 2017-06-30 | −$38.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2017-01-01 to 2017-06-30 | $2.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-04-01 to 2017-06-30 | $1.1m | us-gaap:InterestExpense |
| Interest expense | 6 months2017-01-01 to 2017-06-30 | $2.1m | us-gaap:InterestExpense |
| Income tax | 3 months2017-04-01 to 2017-06-30 | −$16.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2017-01-01 to 2017-06-30 | −$3.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-04-01 to 2017-06-30 | −$21.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2017-01-01 to 2017-06-30 | $8.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-04-01 to 2017-06-30 | −$1.35 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2017-01-01 to 2017-06-30 | $0.49 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-04-01 to 2017-06-30 | −$1.35 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2017-01-01 to 2017-06-30 | $0.51 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-04-01 to 2017-06-30 | 16,010,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2017-01-01 to 2017-06-30 | 16,758,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 6 months2017-01-01 to 2017-06-30 | $28.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2017-01-01 to 2017-06-30 | $8.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2017-01-01 to 2017-06-30 | $85.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-06-30 | $13.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-06-30 | $156.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-06-30 | $910.3m | us-gaap:Assets |
| Current liabilities | At period end2017-06-30 | $268.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-06-30 | $457.2m | us-gaap:Liabilities |
| Long-term debt | At period end2017-06-30 | $115.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2017-06-30 | $10.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2017-06-30 | $453.1m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2017-06-30 | 15,991,878 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001157523-17-002178. Last ingested by Listed: Nov 5, 2026, 15:55 ET. Listed shows no prices and gives no investment advice.